Literature DB >> 3748145

Nuclear factor III, a novel sequence-specific DNA-binding protein from HeLa cells stimulating adenovirus DNA replication.

G J Pruijn, W van Driel, P C van der Vliet.   

Abstract

Dissection and reconstitution of the adenovirus DNA replication machinery has led to the discovery of two HeLa nuclear proteins which are required in conjunction with three viral proteins. One of these, nuclear factor I (NF-I), recognizes an internal region of the origin between nucleotides 25 and 40 and by binding to one side of the helix stimulates the initiation reaction up to 30-fold. NFI-binding sites have been observed upstream of several cellular genes, such as chicken lysozyme, human IgM and human c-myc, and coincide in most cases with DNase I hypersensitive regions. Here we report the identification of a novel DNA-binding protein from HeLa nuclei, designated NF-III, that recognizes a sequence in the adenovirus origin very close to the NFI-binding site, between nucleotides 36 and 54. This sequence includes the partially conserved nucleotides TATGATAATGAG. NF-III stimulates DNA replication four- to sixfold by increasing the initiation efficiency. Potential cellular binding sites include promoter elements of the histone H2B gene, the human interferon beta gene, the human and mouse immunoglobulin VK and VH genes and the mammal/chicken/Xenopus laevis U1 and U2 small nuclear RNA genes. Furthermore, a subset of the herpes simplex virus immediate early promoter specific TAATGARAT elements is homologous with the adenovirus 2 (Ad-2) NFIII-binding site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3748145     DOI: 10.1038/322656a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  103 in total

1.  Identification of conserved residues contributing to the activities of adenovirus DNA polymerase.

Authors:  H Liu; J H Naismith; R T Hay
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

3.  POU domain transcription factors from different subclasses stimulate adenovirus DNA replication.

Authors:  C P Verrijzer; M Strating; Y M Mul; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

4.  Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication.

Authors:  Y M Mul; C P Verrijzer; P C van der Vliet
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

Review 5.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

Review 6.  Recognition mechanisms in the synthesis of animal virus DNA.

Authors:  R T Hay; W C Russell
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

7.  The -6.1-kilobase chicken lysozyme enhancer is a multifactorial complex containing several cell-type-specific elements.

Authors:  T Grewal; M Theisen; U Borgmeyer; T Grussenmeyer; R A Rupp; A Stief; F Qian; A Hecht; A E Sippel
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

8.  Nuclear factor I is specifically targeted to discrete subnuclear sites in adenovirus type 2-infected cells.

Authors:  J Bosher; A Dawson; R T Hay
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  NFI and Oct-1 bend the Ad5 origin in the same direction leading to optimal DNA replication.

Authors:  Monika E Mysiak; Claire Wyman; P Elly Holthuizen; Peter C van der Vliet
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

10.  Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis.

Authors:  K Nagata; H Kawase; H Handa; K Yano; M Yamasaki; Y Ishimi; A Okuda; A Kikuchi; K Matsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.